Literature DB >> 14457003

Evaluation of the antiarrhythmic properties of antazoline. A preliminary study.

S R KLINE, L S DREIFUS, Y WATANABE, T F McGARRY, W LIKOFF.   

Abstract

Entities:  

Keywords:  ANTIHISTAMINICS/therapy; ARRHYTHMIA/therapy

Mesh：

Substances：

Year:  1962        PMID： 14457003     DOI： 10.1016/0002-9149(62)90075-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

1.  Antiarrhythmic actions of clemizole as pharmacologic evidence for a circus movement mechanism in atrial flutter.

Authors:  R Mendez; E Kabela; G Pastelin; M Martínez-López; S Sánchez-Pérez
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

Review 2.  Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.

Authors:  Omar F Hassan; Jassim Al Suwaidi; Amar M Salam
Journal:  J Atr Fibrillation       Date:  2013-06-30

3.  Antazoline in the treatment of cardiac arrhythmias.

Authors:  S S Shah; C H Vaidya; H V Doshi
Journal:  Postgrad Med J       Date:  1972-05       Impact factor: 2.401

4.  Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart.

Authors:  Bartłomiej Jacek Bińkowski; Marcin Makowski; Paweł Kubiński; Andrzej Lubiński
Journal:  Cardiovasc Drugs Ther       Date:  2018-04       Impact factor: 3.727

5.  Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study).

Authors:  Michal M Farkowski; Aleksander Maciag; Rafal Dabrowski; Mariusz Pytkowski; Ilona Kowalik; Hanna Szwed
Journal:  Trials       Date:  2012-09-11       Impact factor: 2.279

Review 6.  The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A?

Authors:  A John Camm
Journal:  Curr Cardiol Rev       Date:  2014-11

7.  Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study.

Authors:  Maciej T Wybraniec; Wojciech Wróbel; Katarzyna Wilkosz; Karolina Wrona; Karolina Bula; Katarzyna Mizia-Stec
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.